Dr. Tycel Phillips discusses the implications of the FDA approval of Calquence plus bendamustine and Rituxan in untreated MCL ...

BostonGene collaborates with BeiGene to advance biomarker discovery in mantle cell lymphoma: Waltham, Massachusetts Thursday, February 13, 2025, 09:00 Hrs [IST] BostonGene, a lead ...

Patients treated in community settings were more likely to be older, less likely to be White, and had worse survival rates, ...

Galapagos NV (Euronext & NASDAQ: GLPG), a global biotechnology company dedicated to transforming patient outcomes through life-changing science and innovation, today reported its financial results for ...

ASH 2024 featured practice-changing studies in lymphoid malignancies, including tafasitamab’s impact in FL, ibrutinib’s OS benefit in MCL, and promising epcoritamab data in CLL.

The show, which debuted on Netflix on 5 February with Holly Willoughby and Bear Grylls at the helm, pits 12 celebrities ...

Gilead Sciences faces revenue growth challenges as its blockbuster drugs lose exclusivity by 2033. Check out my ...